Brighton Jones LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Brighton Jones LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$272K	Buy	+1,719	New	+$232K	0.01%	1105
2024 Q3	–	Sell	-2,240	Closed	-$208K	–	668
2024 Q2	$208K	Buy	+2,240	New	+$201K	0.01%	568
2021 Q1	–	Sell	-1,609	Closed	-$226K	–	449
2020 Q4	$226K	Buy	+1,609	New	+$206K	0.01%	335

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Brighton Jones LLC's XBI Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,719 shares worth $272K. The stake represents 0.01% of the portfolio and ranks #1105 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in XBI as recently as Q2 2024.

Brighton Jones LLC first reported a position in XBI in Q4 2020 and has held it in 3 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Brighton Jones LLC held 1,719 shares of State Street SPDR S&P Biotech ETF worth $272K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Brighton Jones LLC position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1105 holding.
Brighton Jones LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 3 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.